Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh (REGN34) Price & Analysis

Q: Is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh overvalued?

According to Wall Street analysts Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Which hedge fund is a major shareholder of Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh?

Currently, no hedge funds are holding shares in BR:REGN34

― Followers

REGN34 Stock Chart & Stats

R$70.70

R$0.00(0.00%)

Sep 07, 2026

―

Day’s Range― - ―

52-Week RangeR$44.82 - R$80.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)893.00

Market Cap

R$436.85B

Enterprise ValueR$316.27K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)19638.9

Beta0.08

Next Earnings

Oct 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)<0.01

Shares Outstanding6,067,057,000

10 Day Avg. Volume1,070

30 Day Avg. Volume893

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh News

Veeva price target raised to $310 from $270 at Needham

Needham raised the firm’s price target on Veeva (VEEV) to $310 from $270 and keeps a Buy rating...

12d ago

LLY

BIIB

Private Markets: $1B for Base Power, $545M for Whatnot

Two fast growing private companies are drawing attention next week as Base Power rolls out its new grid...

19d ago

Regeneron’s Pasatru granted FDA approval for FOP

The U.S. Food and Drug Administration has approved Pasatru to reduce new heterotopic ossification and reduce clinician-assessed disease...

19d ago

REGN

Regeneron price target raised to $824 from $641 at Leerink

Leerink analyst David Risinger raised the firm’s price target on Regeneron (REGN) to $824 from $641 and keeps...

22d ago

REGN

Private Markets: Databricks secures $5B as Kalshi targets $40B valuation

Databricks’ $5B strategic raise at a $190B valuation underscores the momentum in AI infrastructure, as Kalshi reportedly seeks...

22d ago

IBM

Regeneron announces Health Canada approval of new indication for Libtayo

Regeneron (REGN) Canada announced that Health Canada has issued a Notice of Compliance for Libtayo for the adjuvant...

1M ago

REGN

Regeneron price target raised to $1,030 from $1,000 at Guggenheim

Guggenheim raised the firm’s price target on Regeneron (REGN) to $1,030 from $1,000 and keeps a Buy rating...

1M ago

REGN

Regeneron price target raised to $740 from $700 at Citi

Citi raised the firm’s price target on Regeneron (REGN) to $740 from $700 and keeps a Neutral rating...

1M ago

REGN

Regeneron price target raised to $737 from $696 at RBC Capital

RBC Capital raised the firm’s price target on Regeneron (REGN) to $737 from $696 and keeps a Sector...

1M ago

SNY

REGN

Regeneron price target raised to $758 from $730 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Regeneron (REGN) to $758 from $730 and keeps an Equal...

1M ago

REGN

REGN34 FAQ

What was Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s price range in the past 12 months?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh lowest stock price was R$44.82 and its highest was R$80.00 in the past 12 months.

What is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s market cap?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s market cap is R$436.85B.

When is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s upcoming earnings report date?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s upcoming earnings report date is Oct 29, 2026 which is in 51 days.

How were Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s earnings last quarter?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh released its earnings results on Jul 30, 2026. The company reported R$0.001 earnings per share for the quarter.

Is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh overvalued?

According to Wall Street analysts Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh pay dividends?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh does not currently pay dividends.

What is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s EPS estimate?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh have?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh has 6,067,057,000 shares outstanding.

What happened to Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s price movement after its last earnings report?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh reported an EPS of R$0.001 in its last earnings report. Following the earnings report the stock price went up 2.336%.

Which hedge fund is a major shareholder of Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh?

Currently, no hedge funds are holding shares in BR:REGN34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology